Late-onset seropositive Isaacs' syndrome after Guillain-Barré syndrome

Neuromuscular Disorders

Volumn 19, Issue 4, 2009, Pages 288-290

  Myers, Kenneth A ^a   Baker, Steven K ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Eczematous rash; Guillain Barr syndrome; Intravenous immunoglobulin; Isaacs' syndrome; Neuromyotonia; VGKC antibodies

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CIPROFLOXACIN; CREATINE KINASE; FLUOCINONIDE; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; PERGOLIDE MESILATE; PRAMIPEXOLE; ROPINIROLE; TETANUS TOXOID; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG ERUPTION; ELECTROMYOGRAPHY; EVENING DOSAGE; FOOT ORTHOSIS; GUILLAIN BARRE SYNDROME; HEADACHE; HOSPITALIZATION; HUMAN; LABORATORY TEST; MALE; MOTOR NERVE CONDUCTION; MYOKYMIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REHABILITATION CARE; SEROLOGY;

ANTICONVULSANTS; AUTOANTIBODIES; DOPAMINE AGONISTS; ECZEMA; EXANTHEMA; GUILLAIN-BARRE SYNDROME; HUMANS; IATROGENIC DISEASE; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; ISAACS SYNDROME; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE, SKELETAL; PARALYSIS; PERIPHERAL NERVES; POTASSIUM CHANNELS, VOLTAGE-GATED; SPASM; TETANUS TOXOID;

EID: 63749126116     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.01.007     Document Type: Article

References (21)

1. Maddison P. Neuromyotonia. Clin Neurophys 117 (2006) 2118-2127
2. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 24 (1961) 319-325
3. Falace A., Striano P., Manganelli F., et al. Inherited neuromyotonia: a clinical and genetic study of a family. Neuromuscul Disord 17 (2007) 23-27
4. Shillito P., Molenaar P.C., Vincent A., et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 38 (1995) 714-722
5. Iguchi M., Morimatsu A., Kondo T., Shirata A., and Yamane K. [Case of Isaacs' syndrome associated with Hashimoto disease] (in Japanese). Rinsho Shinkeigaku 47 (2007) 662-664
6. Sategna Guidetti C., Solerio E., Scaglione N., Aimo G., and Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 49 (2001) 502-505
7. Vasilescu C., Alexianu M., and Dan A. Muscle hypertrophy and a syndrome of continuous motor unit activity in prednisone-responsive Guillain-Barré polyneuropathy. J Neurol 231 (1984) 276-279
8. Alessi G., De Reuck J., De Bleecker J., and Vancayzeele S. Successful immunoglobulin treatment in a patient with neuromyotonia. Clin Neurol Neurosurg 102 (2000) 173-175
9. Fawcett R.S., Linford S., and Stulberg D.L. Nail abnormalities: clues to systemic disease. Am Fam Physician 69 (2004) 1417-1424
10. Tuttle J., Chen R.T., Rantala H., Cherry J.D., Rhodes P.H., and Hadler S. The risk of Guillain-Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health 87 (1997) 2045-2048
11. Odabasi Z., Joy J.L., Claussen G.C., Herrera G.A., and Oh S.J. Isaacs' syndrome associated with chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 19 (1996) 210-215
12. Newsom-Davis J., and Mills K.R. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 116 Pt 2 (1993) 453-469
13. Valenstein E., Watson R.T., and Parker J.L. Myokymia, muscle hypertrophy and percussion "myotonia" in chronic recurrent polyneuropathy. Neurology 28 (1978) 1130-1134
14. Hart I.K., Waters C., Vincent A., et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 41 (1997) 238-246
15. Ariga T., and Yu R.K. Antiglycolipid antibodies in Guillain-Barre syndrome and related diseases: review of clinical features and antibody specificities. J Neurosci Res 80 (2005) 1-17
16. Sinha S., Newsom-Davis J., Mills K., Byrne N., Lang B., and Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 338 (1991) 75-77
17. Tan K.M., Lennon V.A., Klein C.J., Boeve B.F., and Pittock S.J. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 70 (2008) 1883-1890
18. Hart I.K., Maddison P., Newsom-Davis J., Vincent A., and Mills K.R. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125 (2002) 1887-1895
19. Nagado T., Arimura K., Sonoda Y., et al. Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 122 (1999) 2057-2066
20. Miyake S., Shimo Y., and Kitamura T. [Morphological differentiation in vitro of human continuous and functional neuroblastoma cell line, NB-I under treatment of (But)2cAMP (author's transl)]. No Shinkei Geka 3 (1975) 407-414
21. Vecchietti G., Kerl K., Prins C., Kaya G., Saurat J.H., and French L.E. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature. Arch Dermatol 142 (2006) 213-217